These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32181937)

  • 1. Psychiatric and neurocognitive consequences of endogenous hypercortisolism.
    Piasecka M; Papakokkinou E; Valassi E; Santos A; Webb SM; de Vries F; Pereira AM; Ragnarsson O
    J Intern Med; 2020 Aug; 288(2):168-182. PubMed ID: 32181937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric disorders associated with Cushing's syndrome.
    Bratek A; Koźmin-Burzyńska A; Górniak E; Krysta K
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S339-43. PubMed ID: 26417792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional brain alterations in Cushing's syndrome.
    Papakokkinou E; Ragnarsson O
    Front Endocrinol (Lausanne); 2023; 14():1163482. PubMed ID: 37152946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric disorders in Cushing's syndrome.
    Pereira AM; Tiemensma J; Romijn JA
    Neuroendocrinology; 2010; 92 Suppl 1():65-70. PubMed ID: 20829621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome.
    Forget H; Lacroix A; Bourdeau I; Cohen H
    Psychoneuroendocrinology; 2016 Mar; 65():26-33. PubMed ID: 26708069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.
    Santos A; Resmini E; Pascual JC; Crespo I; Webb SM
    Drugs; 2017 May; 77(8):829-842. PubMed ID: 28393326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric disorders in Cushing's syndrome.
    Pivonello R; Simeoli C; De Martino MC; Cozzolino A; De Leo M; Iacuaniello D; Pivonello C; Negri M; Pellecchia MT; Iasevoli F; Colao A
    Front Neurosci; 2015; 9():129. PubMed ID: 25941467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing's Syndrome and Steroid Dementia.
    Bernini G; Tricò D
    Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):50-55. PubMed ID: 27515536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission.
    Pupier E; Santos A; Etchamendy N; Lavielle A; Ferriere A; Marighetto A; Resmini E; Cota D; Webb SM; Tabarin A
    Front Endocrinol (Lausanne); 2022; 13():934347. PubMed ID: 36004342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function and cerebral assessment in patients who have Cushing's syndrome.
    Bourdeau I; Bard C; Forget H; Boulanger Y; Cohen H; Lacroix A
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):357-69, ix. PubMed ID: 15850847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.
    Crespo I; Santos A; Gómez-Ansón B; López-Mourelo O; Pires P; Vives-Gilabert Y; Webb SM; Resmini E
    Endocrine; 2016 Sep; 53(3):848-56. PubMed ID: 27103571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's syndrome: a structured short- and long-term management plan for patients in remission.
    Ragnarsson O; Johannsson G
    Eur J Endocrinol; 2013 Nov; 169(5):R139-52. PubMed ID: 23985132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosomatic aspects of Cushing's syndrome.
    Sonino N; Fallo F; Fava GA
    Rev Endocr Metab Disord; 2010 Jun; 11(2):95-104. PubMed ID: 19960264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric Symptoms in Cushing's Syndrome: A Systematic Review.
    Lin TY; Hanna J; Ishak WW
    Innov Clin Neurosci; 2020 Jan; 17(1-3):30-35. PubMed ID: 32547845
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical consequences of Cushing's syndrome.
    Valassi E; Crespo I; Santos A; Webb SM
    Pituitary; 2012 Sep; 15(3):319-29. PubMed ID: 22527617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study.
    Andela CD; van der Werff SJ; Pannekoek JN; van den Berg SM; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Romijn JA; Tiemensma J; Biermasz NR; van der Wee NJ; Pereira AM
    Eur J Endocrinol; 2013 Dec; 169(6):811-9. PubMed ID: 24031092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?
    Wagenmakers MA; Netea-Maier RT; Prins JB; Dekkers T; den Heijer M; Hermus AR
    Eur J Endocrinol; 2012 Nov; 167(5):687-95. PubMed ID: 22936421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol Excess and the Brain.
    Resmini E; Santos A; Webb SM
    Front Horm Res; 2016; 46():74-86. PubMed ID: 27210466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome.
    Na S; Fernandes MA; Ioachimescu AG; Penna S
    Behav Neurol; 2020; 2020():4064370. PubMed ID: 32831970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life impairment after a diagnosis of Cushing's syndrome.
    Webb SM; Valassi E
    Pituitary; 2022 Oct; 25(5):768-771. PubMed ID: 35767164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.